Omar Boraie Chair in Genomic Science Created With $3 Million Endowment At Rutgers

The Omar Boraie Chair in Genomic Science has recently been established at Rutgers University in New Brunswick, New Jersey. This new medical chair has been developed as part of the “18 Chair Challenge” campaign. The campaign seeks to create 18 new chairs with an anonymous donor providing a $1.5 million match to a private donor in order to create the chair.

Omar Boraie is the private donor ponying up $1.5 million. Rutgers University‘s own anonymous donor is matching that donation with $1.5 million to create a $3 million endowment.

The Omar Boraie Chair in Genomic Science seeks to use genomic science to create precision medicine in attacking cancer. By using genomic information about a particular cancer, the scientists at Rutgers can create individualized cancer treatments. This groundbreaking work is critical for those with cancers that have been unresponsive to conventional treatments. See,

The Omar Boraie Chair in Genomic Science is the first group of medical professionals in the country to use genomic sequencing to improve patient care. Those with cancers that are particularly difficult to treat and those with poor prognosis can come to Rutgers University in order to receive treatment tailored to their particular situation.

Omar Boraie is incredibly optimistic about the new chair at the Rutgers Cancer Institute. He hopes that his $1.5 million contribution will encourage others to contribute to the cause. He points at the anonymous donor that matched his $1.5 million contribution as his own inspiration. Mr Boraie says that just as the anonymous donor inspired him to give, he hopes that his public contribution will inspire more to come forward.

Omar Boraie is an integral part of the New Brunswick community. He has long been a part of the development of the area as a “healthcare city” in New Jersey. It is fitting that Omar Boraie have his name on this chair.

The Rutgers Cancer Institute understands that cancer is not a single disease. Instead, cancer is a collection of many diseases with unique features and outcomes. Each cancer must be studied and treated on its own merits. This is exactly what genomic sequencing does for cancer research. Instead of classifying a cancer due to its origin in a singular organ, genomic analysis allows scientists further classification of the disease. The existence of the Omar Boraie Chair in Genomic Science at the Rutgers Cancer Institute will further our understanding of this devastating disease in hopes for a cure down the road.